Global Integrin Alpha 4 Market Insights and Forecast to 2026

Publisher Name :
Date: 01-Jul-2020
No. of pages: 118
Inquire Before Buying

Integrin Alpha 4 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Integrin Alpha 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Integrin Alpha 4 market is segmented into

- TE-5232

- ATL-1102

- Carotegrast

- ET-3764

- Others

Segment by Application, the Integrin Alpha 4 market is segmented into

- Acute Ischemic Stroke

- Celiac Disease

- Epilepsy

- Melanoma

- Multiple Sclerosis

- Other

Regional and Country-level Analysis

The Integrin Alpha 4 market is analysed and market size information is provided by regions (countries).

The key regions covered in the Integrin Alpha 4 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Integrin Alpha 4 Market Share Analysis

Integrin Alpha 4 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Integrin Alpha 4 business, the date to enter into the Integrin Alpha 4 market, Integrin Alpha 4 product introduction, recent developments, etc.

The major vendors covered:

- Amgen Inc

- Antisense Therapeutics Ltd

- Biogen Inc

- BioMAS Ltd

- Daiichi Sankyo Co Ltd

- EA Pharma Co Ltd

- Immunwork Inc

- Morphic Therapeutic Inc

- Protagonist Therapeutics Inc

- Takeda Pharmaceutical Co Ltd

- Viriom Inc

Global Integrin Alpha 4 Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Integrin Alpha 4 Product Introduction
1.2 Market Segments
1.3 Key Integrin Alpha 4 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Integrin Alpha 4 Market Size Growth Rate by Type
1.4.2 TE-5232
1.4.3 ATL-1102
1.4.4 Carotegrast
1.4.5 ET-3764
1.4.6 Others
1.5 Market by Application
1.5.1 Global Integrin Alpha 4 Market Size Growth Rate by Application
1.5.2 Acute Ischemic Stroke
1.5.3 Celiac Disease
1.5.4 Epilepsy
1.5.5 Melanoma
1.5.6 Multiple Sclerosis
1.5.7 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Integrin Alpha 4 Market Size, Estimates and Forecasts
2.1.1 Global Integrin Alpha 4 Revenue 2015-2026
2.1.2 Global Integrin Alpha 4 Sales 2015-2026
2.2 Global Integrin Alpha 4, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Integrin Alpha 4 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Integrin Alpha 4 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Integrin Alpha 4 Competitor Landscape by Players
3.1 Integrin Alpha 4 Sales by Manufacturers
3.1.1 Integrin Alpha 4 Sales by Manufacturers (2015-2020)
3.1.2 Integrin Alpha 4 Sales Market Share by Manufacturers (2015-2020)
3.2 Integrin Alpha 4 Revenue by Manufacturers
3.2.1 Integrin Alpha 4 Revenue by Manufacturers (2015-2020)
3.2.2 Integrin Alpha 4 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Integrin Alpha 4 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Integrin Alpha 4 Revenue in 2019
3.2.5 Global Integrin Alpha 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Integrin Alpha 4 Price by Manufacturers
3.4 Integrin Alpha 4 Manufacturing Base Distribution, Product Types
3.4.1 Integrin Alpha 4 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Integrin Alpha 4 Product Type
3.4.3 Date of International Manufacturers Enter into Integrin Alpha 4 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Integrin Alpha 4 Market Size by Type (2015-2020)
4.1.1 Global Integrin Alpha 4 Sales by Type (2015-2020)
4.1.2 Global Integrin Alpha 4 Revenue by Type (2015-2020)
4.1.3 Integrin Alpha 4 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Integrin Alpha 4 Market Size Forecast by Type (2021-2026)
4.2.1 Global Integrin Alpha 4 Sales Forecast by Type (2021-2026)
4.2.2 Global Integrin Alpha 4 Revenue Forecast by Type (2021-2026)
4.2.3 Integrin Alpha 4 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Integrin Alpha 4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Integrin Alpha 4 Market Size by Application (2015-2020)
5.1.1 Global Integrin Alpha 4 Sales by Application (2015-2020)
5.1.2 Global Integrin Alpha 4 Revenue by Application (2015-2020)
5.1.3 Integrin Alpha 4 Price by Application (2015-2020)
5.2 Integrin Alpha 4 Market Size Forecast by Application (2021-2026)
5.2.1 Global Integrin Alpha 4 Sales Forecast by Application (2021-2026)
5.2.2 Global Integrin Alpha 4 Revenue Forecast by Application (2021-2026)
5.2.3 Global Integrin Alpha 4 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Integrin Alpha 4 by Country
6.1.1 North America Integrin Alpha 4 Sales by Country
6.1.2 North America Integrin Alpha 4 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Integrin Alpha 4 Market Facts & Figures by Type
6.3 North America Integrin Alpha 4 Market Facts & Figures by Application
7 Europe
7.1 Europe Integrin Alpha 4 by Country
7.1.1 Europe Integrin Alpha 4 Sales by Country
7.1.2 Europe Integrin Alpha 4 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Integrin Alpha 4 Market Facts & Figures by Type
7.3 Europe Integrin Alpha 4 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Integrin Alpha 4 by Region
8.1.1 Asia Pacific Integrin Alpha 4 Sales by Region
8.1.2 Asia Pacific Integrin Alpha 4 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Integrin Alpha 4 Market Facts & Figures by Type
8.3 Asia Pacific Integrin Alpha 4 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Integrin Alpha 4 by Country
9.1.1 Latin America Integrin Alpha 4 Sales by Country
9.1.2 Latin America Integrin Alpha 4 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Integrin Alpha 4 Market Facts & Figures by Type
9.3 Central & South America Integrin Alpha 4 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Integrin Alpha 4 by Country
10.1.1 Middle East and Africa Integrin Alpha 4 Sales by Country
10.1.2 Middle East and Africa Integrin Alpha 4 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Integrin Alpha 4 Market Facts & Figures by Type
10.3 Middle East and Africa Integrin Alpha 4 Market Facts & Figures by Application
11 Company Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Corporation Information
11.1.2 Amgen Inc Description and Business Overview
11.1.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Inc Integrin Alpha 4 Products Offered
11.1.5 Amgen Inc Related Developments
11.2 Antisense Therapeutics Ltd
11.2.1 Antisense Therapeutics Ltd Corporation Information
11.2.2 Antisense Therapeutics Ltd Description and Business Overview
11.2.3 Antisense Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Antisense Therapeutics Ltd Integrin Alpha 4 Products Offered
11.2.5 Antisense Therapeutics Ltd Related Developments
11.3 Biogen Inc
11.3.1 Biogen Inc Corporation Information
11.3.2 Biogen Inc Description and Business Overview
11.3.3 Biogen Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biogen Inc Integrin Alpha 4 Products Offered
11.3.5 Biogen Inc Related Developments
11.4 BioMAS Ltd
11.4.1 BioMAS Ltd Corporation Information
11.4.2 BioMAS Ltd Description and Business Overview
11.4.3 BioMAS Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BioMAS Ltd Integrin Alpha 4 Products Offered
11.4.5 BioMAS Ltd Related Developments
11.5 Daiichi Sankyo Co Ltd
11.5.1 Daiichi Sankyo Co Ltd Corporation Information
11.5.2 Daiichi Sankyo Co Ltd Description and Business Overview
11.5.3 Daiichi Sankyo Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Daiichi Sankyo Co Ltd Integrin Alpha 4 Products Offered
11.5.5 Daiichi Sankyo Co Ltd Related Developments
11.6 EA Pharma Co Ltd
11.6.1 EA Pharma Co Ltd Corporation Information
11.6.2 EA Pharma Co Ltd Description and Business Overview
11.6.3 EA Pharma Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 EA Pharma Co Ltd Integrin Alpha 4 Products Offered
11.6.5 EA Pharma Co Ltd Related Developments
11.7 Immunwork Inc
11.7.1 Immunwork Inc Corporation Information
11.7.2 Immunwork Inc Description and Business Overview
11.7.3 Immunwork Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Immunwork Inc Integrin Alpha 4 Products Offered
11.7.5 Immunwork Inc Related Developments
11.8 Morphic Therapeutic Inc
11.8.1 Morphic Therapeutic Inc Corporation Information
11.8.2 Morphic Therapeutic Inc Description and Business Overview
11.8.3 Morphic Therapeutic Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Morphic Therapeutic Inc Integrin Alpha 4 Products Offered
11.8.5 Morphic Therapeutic Inc Related Developments
11.9 Protagonist Therapeutics Inc
11.9.1 Protagonist Therapeutics Inc Corporation Information
11.9.2 Protagonist Therapeutics Inc Description and Business Overview
11.9.3 Protagonist Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Protagonist Therapeutics Inc Integrin Alpha 4 Products Offered
11.9.5 Protagonist Therapeutics Inc Related Developments
11.10 Takeda Pharmaceutical Co Ltd
11.10.1 Takeda Pharmaceutical Co Ltd Corporation Information
11.10.2 Takeda Pharmaceutical Co Ltd Description and Business Overview
11.10.3 Takeda Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Products Offered
11.10.5 Takeda Pharmaceutical Co Ltd Related Developments
11.1 Amgen Inc
11.1.1 Amgen Inc Corporation Information
11.1.2 Amgen Inc Description and Business Overview
11.1.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Inc Integrin Alpha 4 Products Offered
11.1.5 Amgen Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Integrin Alpha 4 Market Estimates and Projections by Region
12.1.1 Global Integrin Alpha 4 Sales Forecast by Regions 2021-2026
12.1.2 Global Integrin Alpha 4 Revenue Forecast by Regions 2021-2026
12.2 North America Integrin Alpha 4 Market Size Forecast (2021-2026)
12.2.1 North America: Integrin Alpha 4 Sales Forecast (2021-2026)
12.2.2 North America: Integrin Alpha 4 Revenue Forecast (2021-2026)
12.2.3 North America: Integrin Alpha 4 Market Size Forecast by Country (2021-2026)
12.3 Europe Integrin Alpha 4 Market Size Forecast (2021-2026)
12.3.1 Europe: Integrin Alpha 4 Sales Forecast (2021-2026)
12.3.2 Europe: Integrin Alpha 4 Revenue Forecast (2021-2026)
12.3.3 Europe: Integrin Alpha 4 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Integrin Alpha 4 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Integrin Alpha 4 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Integrin Alpha 4 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Integrin Alpha 4 Market Size Forecast by Region (2021-2026)
12.5 Latin America Integrin Alpha 4 Market Size Forecast (2021-2026)
12.5.1 Latin America: Integrin Alpha 4 Sales Forecast (2021-2026)
12.5.2 Latin America: Integrin Alpha 4 Revenue Forecast (2021-2026)
12.5.3 Latin America: Integrin Alpha 4 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Integrin Alpha 4 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Integrin Alpha 4 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Integrin Alpha 4 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Integrin Alpha 4 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Integrin Alpha 4 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Integrin Alpha 4 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Integrin Alpha 4 Market Segments
Table 2. Ranking of Global Top Integrin Alpha 4 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Integrin Alpha 4 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of TE-5232
Table 5. Major Manufacturers of ATL-1102
Table 6. Major Manufacturers of Carotegrast
Table 7. Major Manufacturers of ET-3764
Table 8. Major Manufacturers of Others
Table 9. Global Integrin Alpha 4 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Integrin Alpha 4 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Integrin Alpha 4 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Integrin Alpha 4 Sales Market Share by Regions (2015-2020)
Table 13. Global Integrin Alpha 4 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Integrin Alpha 4 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Integrin Alpha 4 Sales Share by Manufacturers (2015-2020)
Table 16. Global Integrin Alpha 4 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Integrin Alpha 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Integrin Alpha 4 as of 2019)
Table 18. Integrin Alpha 4 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Integrin Alpha 4 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Integrin Alpha 4 Price (2015-2020) (USD/Pcs)
Table 21. Integrin Alpha 4 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Integrin Alpha 4 Product Type
Table 23. Date of International Manufacturers Enter into Integrin Alpha 4 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Integrin Alpha 4 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Integrin Alpha 4 Sales Share by Type (2015-2020)
Table 27. Global Integrin Alpha 4 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Integrin Alpha 4 Revenue Share by Type (2015-2020)
Table 29. Integrin Alpha 4 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Integrin Alpha 4 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Integrin Alpha 4 Sales Share by Application (2015-2020)
Table 32. North America Integrin Alpha 4 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Integrin Alpha 4 Sales Market Share by Country (2015-2020)
Table 34. North America Integrin Alpha 4 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Integrin Alpha 4 Revenue Market Share by Country (2015-2020)
Table 36. North America Integrin Alpha 4 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Integrin Alpha 4 Sales Market Share by Type (2015-2020)
Table 38. North America Integrin Alpha 4 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Integrin Alpha 4 Sales Market Share by Application (2015-2020)
Table 40. Europe Integrin Alpha 4 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Integrin Alpha 4 Sales Market Share by Country (2015-2020)
Table 42. Europe Integrin Alpha 4 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Integrin Alpha 4 Revenue Market Share by Country (2015-2020)
Table 44. Europe Integrin Alpha 4 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Integrin Alpha 4 Sales Market Share by Type (2015-2020)
Table 46. Europe Integrin Alpha 4 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Integrin Alpha 4 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Integrin Alpha 4 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Integrin Alpha 4 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Integrin Alpha 4 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Integrin Alpha 4 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Integrin Alpha 4 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Integrin Alpha 4 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Integrin Alpha 4 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Integrin Alpha 4 Sales Market Share by Application (2015-2020)
Table 56. Latin America Integrin Alpha 4 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Integrin Alpha 4 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Integrin Alpha 4 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Integrin Alpha 4 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Integrin Alpha 4 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Integrin Alpha 4 Sales Market Share by Type (2015-2020)
Table 62. Latin America Integrin Alpha 4 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Integrin Alpha 4 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Integrin Alpha 4 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Integrin Alpha 4 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Integrin Alpha 4 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Integrin Alpha 4 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Integrin Alpha 4 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Integrin Alpha 4 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Integrin Alpha 4 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Integrin Alpha 4 Sales Market Share by Application (2015-2020)
Table 72. Amgen Inc Corporation Information
Table 73. Amgen Inc Description and Major Businesses
Table 74. Amgen Inc Integrin Alpha 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Amgen Inc Product
Table 76. Amgen Inc Recent Development
Table 77. Antisense Therapeutics Ltd Corporation Information
Table 78. Antisense Therapeutics Ltd Description and Major Businesses
Table 79. Antisense Therapeutics Ltd Integrin Alpha 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Antisense Therapeutics Ltd Product
Table 81. Antisense Therapeutics Ltd Recent Development
Table 82. Biogen Inc Corporation Information
Table 83. Biogen Inc Description and Major Businesses
Table 84. Biogen Inc Integrin Alpha 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Biogen Inc Product
Table 86. Biogen Inc Recent Development
Table 87. BioMAS Ltd Corporation Information
Table 88. BioMAS Ltd Description and Major Businesses
Table 89. BioMAS Ltd Integrin Alpha 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. BioMAS Ltd Product
Table 91. BioMAS Ltd Recent Development
Table 92. Daiichi Sankyo Co Ltd Corporation Information
Table 93. Daiichi Sankyo Co Ltd Description and Major Businesses
Table 94. Daiichi Sankyo Co Ltd Integrin Alpha 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Daiichi Sankyo Co Ltd Product
Table 96. Daiichi Sankyo Co Ltd Recent Development
Table 97. EA Pharma Co Ltd Corporation Information
Table 98. EA Pharma Co Ltd Description and Major Businesses
Table 99. EA Pharma Co Ltd Integrin Alpha 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. EA Pharma Co Ltd Product
Table 101. EA Pharma Co Ltd Recent Development
Table 102. Immunwork Inc Corporation Information
Table 103. Immunwork Inc Description and Major Businesses
Table 104. Immunwork Inc Integrin Alpha 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Immunwork Inc Product
Table 106. Immunwork Inc Recent Development
Table 107. Morphic Therapeutic Inc Corporation Information
Table 108. Morphic Therapeutic Inc Description and Major Businesses
Table 109. Morphic Therapeutic Inc Integrin Alpha 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Morphic Therapeutic Inc Product
Table 111. Morphic Therapeutic Inc Recent Development
Table 112. Protagonist Therapeutics Inc Corporation Information
Table 113. Protagonist Therapeutics Inc Description and Major Businesses
Table 114. Protagonist Therapeutics Inc Integrin Alpha 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Protagonist Therapeutics Inc Product
Table 116. Protagonist Therapeutics Inc Recent Development
Table 117. Takeda Pharmaceutical Co Ltd Corporation Information
Table 118. Takeda Pharmaceutical Co Ltd Description and Major Businesses
Table 119. Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Takeda Pharmaceutical Co Ltd Product
Table 121. Takeda Pharmaceutical Co Ltd Recent Development
Table 122. Viriom Inc Corporation Information
Table 123. Viriom Inc Description and Major Businesses
Table 124. Viriom Inc Integrin Alpha 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Viriom Inc Product
Table 126. Viriom Inc Recent Development
Table 127. Global Integrin Alpha 4 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 128. Global Integrin Alpha 4 Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Integrin Alpha 4 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Integrin Alpha 4 Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Integrin Alpha 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 132. North America: Integrin Alpha 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Integrin Alpha 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Europe: Integrin Alpha 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Integrin Alpha 4 Sales Forecast by Region (2021-2026) (K Pcs)
Table 136. Asia Pacific: Integrin Alpha 4 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Integrin Alpha 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 138. Latin America: Integrin Alpha 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Integrin Alpha 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 140. Middle East and Africa: Integrin Alpha 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Integrin Alpha 4 Players
Table 145. Integrin Alpha 4 Customers List
Table 146. Integrin Alpha 4 Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Integrin Alpha 4 Product Picture
Figure 2. Global Integrin Alpha 4 Sales Market Share by Type in 2020 & 2026
Figure 3. TE-5232 Product Picture
Figure 4. ATL-1102 Product Picture
Figure 5. Carotegrast Product Picture
Figure 6. ET-3764 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Integrin Alpha 4 Sales Market Share by Application in 2020 & 2026
Figure 9. Acute Ischemic Stroke
Figure 10. Celiac Disease
Figure 11. Epilepsy
Figure 12. Melanoma
Figure 13. Multiple Sclerosis
Figure 14. Other
Figure 15. Integrin Alpha 4 Report Years Considered
Figure 16. Global Integrin Alpha 4 Market Size 2015-2026 (US$ Million)
Figure 17. Global Integrin Alpha 4 Sales 2015-2026 (K Pcs)
Figure 18. Global Integrin Alpha 4 Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Integrin Alpha 4 Sales Market Share by Region (2015-2020)
Figure 20. Global Integrin Alpha 4 Sales Market Share by Region in 2019
Figure 21. Global Integrin Alpha 4 Revenue Market Share by Region (2015-2020)
Figure 22. Global Integrin Alpha 4 Revenue Market Share by Region in 2019
Figure 23. Global Integrin Alpha 4 Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Integrin Alpha 4 Revenue in 2019
Figure 25. Integrin Alpha 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Integrin Alpha 4 Sales Market Share by Type (2015-2020)
Figure 27. Global Integrin Alpha 4 Sales Market Share by Type in 2019
Figure 28. Global Integrin Alpha 4 Revenue Market Share by Type (2015-2020)
Figure 29. Global Integrin Alpha 4 Revenue Market Share by Type in 2019
Figure 30. Global Integrin Alpha 4 Market Share by Price Range (2015-2020)
Figure 31. Global Integrin Alpha 4 Sales Market Share by Application (2015-2020)
Figure 32. Global Integrin Alpha 4 Sales Market Share by Application in 2019
Figure 33. Global Integrin Alpha 4 Revenue Market Share by Application (2015-2020)
Figure 34. Global Integrin Alpha 4 Revenue Market Share by Application in 2019
Figure 35. North America Integrin Alpha 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America Integrin Alpha 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Integrin Alpha 4 Sales Market Share by Country in 2019
Figure 38. North America Integrin Alpha 4 Revenue Market Share by Country in 2019
Figure 39. U.S. Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Integrin Alpha 4 Market Share by Type in 2019
Figure 44. North America Integrin Alpha 4 Market Share by Application in 2019
Figure 45. Europe Integrin Alpha 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe Integrin Alpha 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Integrin Alpha 4 Sales Market Share by Country in 2019
Figure 48. Europe Integrin Alpha 4 Revenue Market Share by Country in 2019
Figure 49. Germany Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Integrin Alpha 4 Market Share by Type in 2019
Figure 60. Europe Integrin Alpha 4 Market Share by Application in 2019
Figure 61. Asia Pacific Integrin Alpha 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Integrin Alpha 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Integrin Alpha 4 Sales Market Share by Region in 2019
Figure 64. Asia Pacific Integrin Alpha 4 Revenue Market Share by Region in 2019
Figure 65. China Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Integrin Alpha 4 Market Share by Type in 2019
Figure 88. Asia Pacific Integrin Alpha 4 Market Share by Application in 2019
Figure 89. Latin America Integrin Alpha 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Integrin Alpha 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Integrin Alpha 4 Sales Market Share by Country in 2019
Figure 92. Latin America Integrin Alpha 4 Revenue Market Share by Country in 2019
Figure 93. Mexico Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Integrin Alpha 4 Market Share by Type in 2019
Figure 100. Latin America Integrin Alpha 4 Market Share by Application in 2019
Figure 101. Middle East and Africa Integrin Alpha 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa Integrin Alpha 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Integrin Alpha 4 Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Integrin Alpha 4 Revenue Market Share by Country in 2019
Figure 105. Turkey Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Integrin Alpha 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E Integrin Alpha 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Integrin Alpha 4 Market Share by Type in 2019
Figure 112. Middle East and Africa Integrin Alpha 4 Market Share by Application in 2019
Figure 113. North America Integrin Alpha 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Integrin Alpha 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Integrin Alpha 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Integrin Alpha 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Integrin Alpha 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Integrin Alpha 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Integrin Alpha 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Integrin Alpha 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Integrin Alpha 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Integrin Alpha 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs